Stock DiscoverySign in
Back to Discover

COLLEGIUM PHARMACEUTICAL, INC

COLL · Biotech · Nasdaq · As of 10 Sep 2026
47AIR SCORE
  • FundamentalsNot enough data yet
  • ValueNot enough data yet
  • News flowBalanced
  • MomentumWeak
  • SafetyStrong

Overall confidence 37/100 — few inputs available yet

Fundamental score not available. AIR's fundamental engine is built for businesses with established revenue and cash flow; biotech financial profiles — often R&D-heavy or pre-revenue — don't yet fit the measures it requires. AIR still assesses this company on discovery, market confirmation and risk, at reduced overall confidence.

Discovery Gap: Very high (81/100) · Gap confidence 61/100Documented progress is running well ahead of market attention.

This month at a glance

AIR Score™ change: 0AIR Score™ held steady this month.
Cycle window9 Sep 2026 → 10 Sep 2026
MoversNothing moved meaningfully this month.

Evidence timeline

  1. [8-K 8.01] COLLEGIUM PHARMACEUTICAL, INC — Other EventsSEC · SEC EDGAR
    Aug 12, 2026 · FORM 8-K
  2. [8-K 2.02] COLLEGIUM PHARMACEUTICAL, INC — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Aug 6, 2026 · 8-K
  3. [8-K 2.01] COLLEGIUM PHARMACEUTICAL, INC — Completion of Acquisition or Disposition of AssetsSEC · SEC EDGAR
    May 12, 2026 · FORM 8-K
  4. [8-K 5.02] COLLEGIUM PHARMACEUTICAL, INC — Departure/Election of Directors or Principal OfficersSEC · SEC EDGAR
    May 12, 2026 · FORM 8-K
  5. [8-K 2.02] COLLEGIUM PHARMACEUTICAL, INC — Results of Operations and Financial ConditionSEC · SEC EDGAR
    May 7, 2026 · 8-K
  6. [8-K 5.02] COLLEGIUM PHARMACEUTICAL, INC — Departure/Election of Directors or Principal OfficersSEC · SEC EDGAR
    Apr 2, 2026 · 8-K
  7. [8-K 1.01] COLLEGIUM PHARMACEUTICAL, INC — Entry into a Material Definitive AgreementSEC · SEC EDGAR
    Mar 19, 2026 · FORM 8-K
  8. [8-K 2.02] COLLEGIUM PHARMACEUTICAL, INC — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Feb 26, 2026 · 8-K
  9. [8-K 1.01] COLLEGIUM PHARMACEUTICAL, INC — Entry into a Material Definitive AgreementSEC · SEC EDGAR
    Dec 23, 2025 · FORM 8-K
  10. [8-K 3.02] COLLEGIUM PHARMACEUTICAL, INC — Unregistered Sales of Equity SecuritiesSEC · SEC EDGAR
    Dec 23, 2025 · FORM 8-K
  11. [8-K 1.02] COLLEGIUM PHARMACEUTICAL, INC — Termination of a Material Definitive AgreementSEC · SEC EDGAR
    Dec 23, 2025 · FORM 8-K
  12. [8-K 2.02] COLLEGIUM PHARMACEUTICAL, INC — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Nov 6, 2025 · 8-K

Ask AIR

What would change our view

A weaker balance sheet in the next filing cycle, a material regulatory setback, or attention arriving — which closes the gap by design would move the score, and the page would show which one did.

Research, not tips. No buy/sell recommendations, no price forecasts. Every score is derived from public filings and market data — figures round to whole numbers and refresh each trading day.